InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
0
T+90 hit rate
67%
T+90 mean return
-12.5%
Across 6 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the complete record of transactions filed by Spiess Bernhard E., Directeur Commercial. Director active across 1 company, notably Castle Biosciences INC. In total, 6 filings have been recorded. History available since 8 June 2021. The latest transaction was disclosed on 2 September 2021 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Declarations6 total
1,500 sharesCommon StockSEC:0001447362-21-000270:0
1,500 sharesCommon StockSEC:0001447362-21-000270
8,989 shares@ US$1.920.0013% mcap25.3% of flowCommon StockSEC:0001447362-21-000213:0
8,989 shares@ US$1.9225.3% of flowCommon StockSEC:0001447362-21-000213
8,989 shares@ US$1.9224.7% of flowCommon StockSEC:0001447362-21-000130
8,989 shares@ US$1.920.0012% mcap24.7% of flowCommon StockSEC:0001447362-21-000130:0
6 of 6 declarations
About Spiess Bernhard E.
Bernhard E. Spiess is the Chief Business Officer at Castle Biosciences Inc. He is responsible for the company's business strategy and development. His role is essential in ensuring the growth and expansion of Castle Biosciences. Bernhard brings expertise in business development and market strategy.
